» Articles » PMID: 13679456

Tyrosinase RT-PCR As a Supplement to Histology for Detecting Melanoma and Nevus Cells in Paraffin Sections of Sentinel Lymph Nodes

Overview
Journal Mod Pathol
Specialty Pathology
Date 2003 Sep 19
PMID 13679456
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The detection of tyrosinase mRNA in sentinel lymph nodes (SLNs) by reverse transcription polymerase chain reaction (RT-PCR) is a sensitive indicator for the presence of melanoma or nevus cells, but it does not enable a distinction between both. We have established an efficient method for extraction and reverse transcription of tyrosinase mRNA from paraffin sections that permits the close correlation of the RT-PCR results with (immuno)histologic findings in adjacent sections. One hundred fifty-three SLNs and 6 non-SLN specimens originating from 92 melanoma and 4 nonmelanoma patients were studied to test the reliability of this approach. The predictive value of positive RT-PCR results was 0.98 for the presence of melanoma or nevus cells; the corresponding negative predictive value was 0.83. Furthermore, the detection rate of tyrosinase mRNA significantly correlated with tumor burden. Among the 33 melanoma-positive SLNs without nevus cells, positive RT-PCR results were obtained in all specimens with extended peripheral (S2) or deeply invasive (S3) micrometastases but in only 46% of the cases with few localized melanoma cells in the subcapsular zone (S1). Routine (immuno)histologic evaluation alone had missed microclusters of melanoma cells in one SLN and small nevus cell aggregates in six other SLNs. They were detected only during microscopic reexamination caused by a positive RT-PCR result. We conclude that histology and immunohistochemistry remain the indispensable gold standard for the identification of melanoma and nevus cells in SLNs. Additional molecular analyses using adjacent paraffin sections may further improve the diagnostic accuracy by sensitizing and guiding the microscopist's attention.

Citing Articles

Prognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up.

Eigentler T, Hinderer J, Noor S, Garbe C, Leiter U J Cancer Res Clin Oncol. 2016; 143(4):703-708.

PMID: 27995312 DOI: 10.1007/s00432-016-2323-0.


Decoding melanoma metastasis.

Damsky W, Rosenbaum L, Bosenberg M Cancers (Basel). 2013; 3(1):126-63.

PMID: 24212610 PMC: 3756353. DOI: 10.3390/cancers3010126.


"Stealth" melanoma cells in histology-negative sentinel lymph nodes.

Itakura E, Huang R, Wen D, Cochran A Am J Surg Pathol. 2011; 35(11):1657-65.

PMID: 21997686 PMC: 3203732. DOI: 10.1097/PAS.0b013e3182322cf7.


EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Chakera A, Hesse B, Burak Z, Ballinger J, Britten A, Caraco C Eur J Nucl Med Mol Imaging. 2009; 36(10):1713-42.

PMID: 19714329 DOI: 10.1007/s00259-009-1228-4.


Melanoma biomarkers: current status and vision for the future.

Larson A, Konat E, Alani R Nat Clin Pract Oncol. 2008; 6(2):105-17.

PMID: 19107110 DOI: 10.1038/ncponc1296.